Lung cancer latency and asbestos liability

Our plain-English summary of Lung cancer latency and asbestos liability, by P. Mustacchi (The Journal of Legal Medicine, 1996).

The study

• Author: P. Mustacchi
• Journal: The Journal of Legal Medicine
• Published: 1996;17(2):277-300
• Cited by: 2 articles, as counted by NIH iCite
• Read it: PubMed · Publisher

In plain English

This 1996 article was a review, not a new study. It reviewed cancer latency, customarily timed from first exposure, a convention the author noted can overestimate true latency, which begins at cancer induction. It also reviewed how California and federal longshore compensation law treat latency. It recalculated mortality rates from published data on 17,800 insulators and presented selected data on 820 amosite factory workers. Among insulators, lung cancer deaths within 15 years of first exposure (7 observed, 3.9 expected) were not significantly increased; no mesothelioma deaths occurred that early. The insulators' lung cancer standardized mortality ratio was 375. The author used their death rates to propose liability shares across five-year exposure periods. Assuming each carcinogen's effect was proportional to its excess risk alone, the author estimated that, for lung cancer in a smoker with asbestos exposure comparable to the insulators', asbestos accounted for some 28%, smoking 70% and background factors 2%. The author concluded that exposures within 15 years of lung cancer death (17.5 for mesothelioma) were unlikely to be causally related. Applying population data to individuals, the author noted, may not be valid.

We wrote this plain-English summary from the full article with the help of AI, and a second AI model checked each sentence against the article. It is not the authors' wording; the abstract and the article are their own account.

What the study did and found

• Design: Review of medical aspects of cancer latency and of related court decisions, with the author's recalculation of previously published mortality data (no new data collected)
• Who was studied: Published data on 17,800 North American insulators and asbestos workers followed for 20 years (1967-1987), and selected published data on 820 amosite factory workers. The article also discusses California and federal compensation cases.
• Exposure: Occupational asbestos exposure. The insulators first worked with chrysotile, which was later replaced by amosite, at estimated time-weighted averages of 4-12 fibers/ml. The factory workers were exposed to amosite, with cumulative exposure measured in fiber-years per ml.
• Main results:
  • Among insulators, lung cancer deaths within 15 years of first exposure: observed 7, expected 3.9, not statistically significant
  • Among insulators, no mesothelioma deaths occurred before 15 years from onset of exposure (458 mesothelioma deaths in total)
  • The insulators' lung cancer SMR was 375 (1,008 observed versus 269 expected)
  • Using the insulators' lung cancer death rates, the author proposed these shares of causation by time of exposure before death: 30-34 years, 55.1%; 25-29 years, 27.7%; 20-24 years, 12.0%; 15-19 years, 5.2%; less than 15 years, 0%
  • In the published amosite factory worker data, higher cumulative exposure was linked to shorter minimum observed lung cancer latency: 50 and over f-y/ml, 10-14 years; less than 6 f-y/ml, 25-29 years
  • The author assumed that each carcinogen's impact was proportional to its excess risk when acting alone, using published relative risks of 5 for non-smoking asbestos workers and 11 for smokers not exposed to asbestos. On that basis, the author estimated that for lung cancer in a worker who smoked and whose asbestos exposure was comparable to the insulators', asbestos would account for some 28%, smoking for 70%, and background factors for 2%.
• The authors' conclusion: The author concluded that asbestos exposures within 15 years of death from lung cancer (or 17.5 years for mesothelioma) are unlikely to be causally related to the cancer. The author also concluded that cumulative dose could help estimate minimum latency, and that observed mortality rates could provide an empiric basis for apportioning causation among carriers or between asbestos and smoking.
• Limitations the authors state:
  • The estimates are crude because constant risks within each exposure interval were used
  • The method assumes there were no relevant carcinogenic exposures before the earliest date used
  • Factors other than asbestos may have contributed to the mortality data used
  • Applying population-level epidemiologic data to an individual case may not be valid
  • The insulators study included only males and gave no updated smoking information
  • Timing latency from first exposure can lead to overestimates

Topics

The National Library of Medicine indexes this study under subjects our site covers: Asbestosis, Lung cancer, Mesothelioma.

Medical terms in this study, explained in our Lexicon: Lung Cancer, Latency.

Related studies

• Insurance, reinsurance and underwriting names' liability for asbestos-related diseases — M. Weller (1992)
• Justice for asbestos victims and the politics of compensation: the French experience — A. Thébaud-Mony (2003)
• The James Hardie story: asbestos victims' claims evaded by manufacturer — B. Hills (2005)
• Product liability forecasting for asbestos-related personal injury claims: a multidisciplinary approach — E. Stallard (2001)
• Pulmonary abnormalities as a result of exposure to Libby amphibole during childhood and adolescence-The Pre-Adult Latency Study (PALS) — J. Szeinuk, C.W. Noonan, et al. (2017)
• Latency periods in neoplastic diseases — A.P. Polednak (1974)

Browse return to medical research.